Kintara Therapeutics Inc
NASDAQ:KTRA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Kintara Therapeutics Inc
NASDAQ:KTRA
|
US |
|
Crescent NV
XBRU:OPTI
|
BE |
|
Stonebridge Acquisition Corp
NASDAQ:FAAS
|
US |
|
BlueScope Steel Ltd
ASX:BSL
|
AU |
|
Genius Metals Inc
XTSX:GENI
|
CA |
|
Polarean Imaging PLC
LSE:POLX
|
US |
|
Lulu's Fashion Lounge Holdings Inc
NASDAQ:LVLU
|
US |
|
R
|
Remgro Ltd
JSE:REM
|
ZA |
|
Y
|
Youngchang Chemical Co Ltd
KOSDAQ:112290
|
KR |
Intrinsic Value
The intrinsic value for
Kintara Therapeutics Inc (KTRA) under the Base Case is hidden
USD.
Compared with the current market price of 6.3 USD, the stock appears hidden
.
Do our valuations actually work? See backtest results .
KTRA looks overvalued.
But is it expensive by its own standards?
See how today’s valuation compares with KTRA’s past valuations and how the stock performed after similar periods.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Kintara Therapeutics Inc.
Fundamental Analysis
Revenue & Expenses Breakdown
Kintara Therapeutics Inc
Earnings Waterfall
Kintara Therapeutics Inc
The intrinsic value for
Kintara Therapeutics Inc (KTRA) under the Base Case is hidden USD.
Compared with the current market price of 6.3 USD, the stock appears hidden.